The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling
Open accessAbstract
Background— Cellular hypertrophy requires coordinated regulation of progrowth and antigrowth mechanisms. In cultured neonatal cardiomyocytes, Foxo transcription factors trigger an atrophy-related gene program that counters hypertrophic growth. However, downstream molecular events are not yet well defined. Methods and Results— Here, we report that expression of either Foxo1 or Foxo3 in cardiomyocytes attenuates calcineurin phosphatase activity and inhibits agonist-induced hypertrophic growth. Consistent with these results, Foxo proteins decrease calcineurin phosphatase activity and repress both basal and hypertrophic agonist-induced expression of MCIP1.4, a direct downstream target of the calcineurin/NFAT pathway. Furthermore, hearts from Foxo3-null mice exhibit increased MCIP1.4 abundance and a hypertrophic phenotype with normal systolic function at baseline. Together, these results suggest that Foxo proteins repress cardiac growth at least in part through inhibition of the calcineurin/NFAT pathway. Given that hypertrophic growth of the heart occurs in multiple contexts, our findings also suggest that certain hypertrophic signals are capable of overriding the antigrowth program induced by Foxo. Consistent with this, multiple hypertrophic agonists triggered inactivation of Foxo proteins in cardiomyocytes through a mechanism requiring the PI3K/Akt pathway. In addition, both Foxo1 and Foxo3 are phosphorylated and consequently inactivated in hearts undergoing hypertrophic growth induced by hemodynamic stress. Conclusions— This study suggests that inhibition of the calcineurin/NFAT signaling cascade by Foxo and release of this repressive action by the PI3K/Akt pathway are important mechanisms whereby Foxo factors govern cell growth in the heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Suppression of Ovarian Follicle Activation in Mice by the Transcription Factor Foxo3a
Castrillon, D. H., Miao, L., Kollipara, R., Horner, J. W., & DePinho, R. A. (2003) · Science · doi:10.1126/science.1086336 · Cited by 952
Self-citationHypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Self-citationHosaka, T., Biggs, W. H., Tieu, D., Boyer, A. D., Varki, N. M., Cavenee, W. K., & Arden, K. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400093101 · Cited by 684
Protein kinase cascades in the regulation of cardiac hypertrophy
Dorn, G. W., & Force, T. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524178 · Cited by 638
Left ventricular volume from paired biplane two-dimensional echocardiography.
Schiller, N. B., Acquatella, H., Ports, T. A., Drew, D., Goerke, J., Ringertz, H., Silverman, N. H., Brundage, B., Botvinick, E. H., Boswell, R., et al. (1979) · Circulation · doi:10.1161/01.cir.60.3.547 · Cited by 610
Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400674200 · Cited by 576
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 535
Tran, H., Brunet, A., Griffith, E. C., & Greenberg, M. E. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re5 · Cited by 434
Li, H.-H., Kedar, V., Zhang, C., McDonough, H., Arya, R., Wang, D.-Z., & Patterson, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422220 · Cited by 430
Yang, J., Rothermel, B., Vega, R. B., Frey, N., McKinsey, T. A., Olson, E. N., Bassel-Duby, R., & Williams, R. S. (2000) · Circulation Research · doi:10.1161/01.res.87.12.e61 · Cited by 354
Self-citationThe FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling
Skurk, C., Izumiya, Y., Maatz, H., Razeghi, P., Shiojima, I., Sandri, M., Sato, K., Zeng, L., Schiekofer, S., Pimentel, D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500528200 · Cited by 353
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
Kedar, V., McDonough, H., Arya, R., Li, H.-H., Rockman, H. A., & Patterson, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404341102 · Cited by 347
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309
Self-citationPhosphorylation of Serine 256 Suppresses Transactivation by FKHR (FOXO1) by Multiple Mechanisms
Zhang, X., Gan, L., Pan, H., Guo, S., He, X., Olson, S. T., Mesecar, A., Adam, S., & Unterman, T. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208063200 · Cited by 294
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Self-citationDose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C.-L., Schreiber, K., Rindt, H., Gorczynski, R. J., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303113200 · Cited by 269
Aoki, M., Jiang, H., & Vogt, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405454101 · Cited by 234
Does load-induced ventricular hypertrophy progress to systolic heart failure?
Berenji, K., Drazner, M. H., Rothermel, B. A., & Hill, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01303.2004 · Cited by 217
Self-citationThe Role of Modulatory Calcineurin-Interacting Proteins in Calcineurin Signaling
Rothermel, B. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00188-3 · Cited by 176
Self-citationCell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways
Zou, Y., Komuro, I., Yamazaki, T., Kudoh, S., Aikawa, R., Zhu, W., Shiojima, I., Hiroi, Y., Tobe, K., Kadowaki, T., et al. (1998) · Circulation Research · doi:10.1161/01.res.82.3.337 · Cited by 145
Akt Mediates the Cross-Talk Between β-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes
Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Condorelli, G., Sadoshima, J., & Trimarco, B. (2005) · Circulation Research · doi:10.1161/01.res.0000152968.71868.c3 · Cited by 141
Control of Cardiac Growth and Function by Calcineurin Signaling
Vega, R. B., Bassel‐Duby, R., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300023200 · Cited by 132
Efficient Generation of Recombinant Adenoviral Vectors by Cre-lox Recombination In Vitro
Aoki, K., Barker, C. S., Danthinne, X., Imperiale, M. J., & Nabel, G. J. (1999) · Molecular Medicine · doi:10.1007/bf03402119 · Cited by 120
van Rooij, E., Doevendans, P. A., Crijns, H. J. G. M., Heeneman, S., Lips, D. J., van Bilsen, M., Williams, R. S., Olson, E. N., Bassel‐Duby, R., Rothermel, B. A., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000118597.54416.00 · Cited by 116
Self-citationHarris, C. D., Ermak, G., & Davies, K. J. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5085-4 · Cited by 106
Calcineurin Is Necessary for the Maintenance but Not Embryonic Development of Slow Muscle Fibers
Oh, M., Rybkin, I. I., Copeland, V., Czubryt, M. P., Shelton, J. M., van Rooij, E., Richardson, J. A., Hill, J. A., Windt, L. J. D., Bassel‐Duby, R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6629-6638.2005 · Cited by 99
Self-citationBush, E. W., Fielitz, J., Melvin, L., Arnold, M., McKinsey, T. A., Plichta, R. P., & Olson, E. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308723101 · Cited by 94
Akt Is a Major Downstream Target of PI3-Kinase Involved in Angiotensin II–Induced Proliferation
Dugourd, C., Gervais, M., Corvol, P. L., & Monnot, C. (2003) · Hypertension · doi:10.1161/01.hyp.0000060821.62417.35 · Cited by 87
Kodama, H., Fukuda, K., Pan, J., Sano, M., Takahashi, T., Katō, T., Makino, S., Manabe, T., Murata, M., & Ogawa, S. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1635 · Cited by 82
Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure
Rothermel, B. A., Berenji, K., Tannous, P., Kutschke, W. J., Dey, A., Nolan, B., Yoo, K., Demetroulis, E., Gimbel, M. L., Cabuay, B. M., et al. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00061.2005 · Cited by 71
Self-citationOka, T., Dai, Y., & Molkentin, J. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6649-6659.2005 · Cited by 47
Cited by
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
Self-citationRedox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
“Therefore, NFAT inhibition might be indirect and mediated by a reduction in ROS levels.”
BackgroundThe miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ucar, A., Gupta, S. K., Fiedler, J., Erikci, E., Kardasinski, M., Batkai, S., Dangwal, S., Kumarswamy, R., Bang, C., Holzmann, A., et al. (2012) · Nature Communications · doi:10.1038/ncomms2090 · Cited by 610
Ageing, metabolism and cardiovascular disease
Costantino, S., Paneni, F., & Cosentino, F. (2016) · The Journal of Physiology · doi:10.1113/jp270538 · Cited by 463
MAPK/JNK signalling: a potential autophagy regulation pathway
Zhou, Y.-Y., Li, Y., Jiang, W.-Q., & Zhou, L.-F. (2015) · Bioscience Reports · doi:10.1042/bsr20140141 · Cited by 444
Metadata
- Authors
- Ni, Y. G., Berenji, K., Wang, N., Oh, M., Sachan, N., Dey, A., Cheng, J., Lu, G., Morris, D. J., Castrillon, D. H., Gerard, R. D., Rothermel, B. A., & Hill, J. A.
- Venue
- Circulation
- Published
- 2006-09-12
- Volume
- 114
- Issue
- 11
- Pages
- 1159-1168
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2131842004
- Cited by
- 312
- References
- 38
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.